Table 4:
Clinical characteristics, treatment strategy, and response in 13 patients with DAVF types with CVD
| Case No. | Sex | Age (yr) | Cognard Type before SRS | Treatment | Cognard Type after Venoplasty/Stent | Treatment after SRS | Follow-Up Duration (mo) | Response |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 41 | IIa+b | Venoplasty/stent | IIa | – | 46 | PR |
| 2 | M | 63 | IIa+b | Venoplasty | IIa | – | 38 | CR |
| 3 | M | 56 | IIa+b | Venoplasty/stent | IIa | – | 19 | PRa |
| 4 | M | 45 | IIa+b | – | NA | – | 15 | CR |
| 5 | F | 63 | IIa+b | Venoplasty/stent | IIa+b | – | 10 | PRa |
| 6 | M | 73 | IIa+b | – | NA | – | 10 | PR |
| 7 | M | 17 | IIa+b | Venoplasty/stent | IIa+b | – | 6 | PR |
| 8 | M | 55 | IIb | – | NA | – | 5.6 | PR |
| 9 | M | 19 | III | – | NA | TAE twice | 17 | PR |
| 10 | M | 27 | III | Venoplasty | IIa | – | 27 | CRb |
| 11 | M | 12 | III | – | – | 13 | CR | |
| 12 | M | 27 | IV | – | – | 27.6 | PR | |
| 13 | M | 55 | IV | – | – | NA | NA |
Note:—TAE indicates transarterial embolization; CR, complete regression; PR, partial regression; –, no adjunct treatment was performed; NA, not available.
a
Restenosis of sinus after venoplasty and stenting.
b
Asymptomatic intracranial hemorrhage on MR imaging.